Cubist Pharmaceuticals Inc. (CBST) traded in a range for the majority of Monday's session, but broke out sharply to the upside in late trade. The stock finished up by 3.97 at $53.48 on the highest volume of the year.
Cubist Pharmaceuticals surged past resistance and set a new high for the year. The jump in late trade was triggered by a ruling in favor of the company by U.S. District Court Judge Gregory M. Sleet in a Delaware court, in a patent case with Hospira Inc. (HSP).
For comments and feedback: editorial@rttnews.com